Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allergenic extract of sugar maple pollen
- Development stage
- Unknown
- Lead developer
- Greer Laboratories
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intradermal, Percutaneous, Subcutaneous
01
Overview
Acer saccharum pollen is a non-standardized biological allergenic extract derived from the pollen of the sugar maple tree (Acer saccharum). It is used for both the diagnosis (via skin testing) and treatment (via immunotherapy) of individuals with immediate hypersensitivity (Type I allergy) to this specific pollen. For diagnostic purposes, the extract is applied percutaneously or intradermally to elicit a localized allergic reaction (wheal and flare) in sensitized individuals. For therapeutic use, it is administered subcutaneously in gradually increasing doses. This process, known as allergen immunotherapy, aims to induce immune tolerance by modulating the body's response to the allergen, thereby reducing the severity of allergic symptoms upon natural exposure. It is available as a single-allergen extract and is also a component of multi-tree pollen mixes. Key manufacturers of these extracts include Stallergenes Greer and Nelco Laboratories.
- Other names
- Acer saccharum pollenSugar maple pollen extractHard maple pollen extractSugar maple pollen
02
Targets
A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)
Beyond the preview
Go deeper on Allergenic extract of sugar maple pollen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allergenic extract of sugar maple pollen.